The Roles, Activities, and Opportunities of Clinical Pharmacists in a National Initiative to Improve Office-Based Buprenorphine Care Article Swipe
Spencer Calder
,
Marie E. Kenny
,
Terri Jorgenson
,
Eric J. Hawkins
,
Adam J. Gordon
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1177/29768357251381070
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1177/29768357251381070
Background: Implementing buprenorphine medication treatment for opioid use disorder (B-MOUD) in office-based, non-addiction specialty care settings is challenging. Clinical pharmacist practitioners (CPPs) can facilitate this care. The Veterans Health Administration’s (VHA) Stepped Care for Opioid Use Disorder Train the Trainer Initiative (SCOUTT) implemented B-MOUD in primary care, mental health, and pain clinics across 37 VHA facilities. B-MOUD activities provided by CPPs within SCOUTT are not well known. Objectives: We sought to examine CPPs’ roles, typical activities, and opportunities to provide B-MOUD. Design: We performed a cross-sectional survey of CPPs within SCOUTT facilities. Methods: In March 2023, known CPPs in SCOUTT clinics were invited via email to participate in an online survey. We also emailed local SCOUTT leaders to forward the invitation to CPPs not initially invited. The anonymous survey gathered information on clinic settings, CPP roles in 25 B-MOUD related tasks (eg, patient intake, risk assessment, initiation), state licensure, and whether they had or desired controlled substance prescriptive authority for B-MOUD. Results: Twenty-two CPPs responded to the survey working in pain (40.9%), primary care (27.3%), mental health (22.7%), and primary care mental health integrated (22.7%) settings. Nearly all (95.5%) reported involvement in naloxone education and distribution and patient management after B-MOUD initiation. Additionally, 90.9% reviewed and interpreted urine drug test results, 90.9% conducted B-MOUD follow-up (assessing side effects or treatment outcomes) and 72.7% assisted in B-MOUD initiation. Most CPPs (95.5%) indicated they work in a team-based environment often acting as a medication expert, were prescribing B-MOUD (27.3%), or desired to do so (86.4%). Conclusion: In the VHA’s SCOUTT Initiative, CPPs play a significant role in leading and collaboratively facilitating B-MOUD. The VHA’s SCOUTT approach to CPP management and B-MOUD prescribing efforts may be a model to emulate in other health systems to improve access to and management of B-MOUD care.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/29768357251381070
- OA Status
- hybrid
- References
- 45
- OpenAlex ID
- https://openalex.org/W4416274747
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416274747Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/29768357251381070Digital Object Identifier
- Title
-
The Roles, Activities, and Opportunities of Clinical Pharmacists in a National Initiative to Improve Office-Based Buprenorphine CareWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-01Full publication date if available
- Authors
-
Spencer Calder, Marie E. Kenny, Terri Jorgenson, Eric J. Hawkins, Adam J. GordonList of authors in order
- Landing page
-
https://doi.org/10.1177/29768357251381070Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1177/29768357251381070Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
45Number of works referenced by this work
Full payload
| id | https://openalex.org/W4416274747 |
|---|---|
| doi | https://doi.org/10.1177/29768357251381070 |
| ids.doi | https://doi.org/10.1177/29768357251381070 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41262846 |
| ids.openalex | https://openalex.org/W4416274747 |
| fwci | 0.0 |
| type | article |
| title | The Roles, Activities, and Opportunities of Clinical Pharmacists in a National Initiative to Improve Office-Based Buprenorphine Care |
| biblio.issue | |
| biblio.volume | 19 |
| biblio.last_page | 29768357251381070 |
| biblio.first_page | 29768357251381070 |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1177/29768357251381070 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4390648488 |
| locations[0].source.issn | 2976-8357 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2976-8357 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Substance Use Research and Treatment |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Substance Use: Research and Treatment |
| locations[0].landing_page_url | https://doi.org/10.1177/29768357251381070 |
| locations[1].id | pmid:41262846 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Substance use : research and treatment |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41262846 |
| locations[2].id | pmh:oai:europepmc.org:11431890 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12623655 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5029172752 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Spencer Calder |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210089864 |
| authorships[0].affiliations[0].raw_affiliation_string | Vulnerable Veteran Innovative Patient-Aligned-Care-Team (VIP) Initiative, Veterans Administration Health Systems Research (VA HSR) Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, UT, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I223532165 |
| authorships[0].affiliations[1].raw_affiliation_string | Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA |
| authorships[0].institutions[0].id | https://openalex.org/I223532165 |
| authorships[0].institutions[0].ror | https://ror.org/03r0ha626 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I223532165 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Utah |
| authorships[0].institutions[1].id | https://openalex.org/I4210089864 |
| authorships[0].institutions[1].ror | https://ror.org/007fyq698 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I1322918889, https://openalex.org/I2799886695, https://openalex.org/I4210089864, https://openalex.org/I4210113540 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | VA Salt Lake City Healthcare System |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Spencer G. Calder |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA, Vulnerable Veteran Innovative Patient-Aligned-Care-Team (VIP) Initiative, Veterans Administration Health Systems Research (VA HSR) Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, UT, USA |
| authorships[1].author.id | https://openalex.org/A5040019303 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6808-3146 |
| authorships[1].author.display_name | Marie E. Kenny |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210117246 |
| authorships[1].affiliations[0].raw_affiliation_string | Center for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, MN, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210117246 |
| authorships[1].institutions[0].ror | https://ror.org/02ry60714 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1322918889, https://openalex.org/I2799886695, https://openalex.org/I4210117246, https://openalex.org/I4210117924 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Minneapolis VA Health Care System |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marie E. Kenny |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Center for Care Delivery & Outcomes Research, Minneapolis Veterans Affairs Health Care System, MN, USA |
| authorships[2].author.id | https://openalex.org/A5082531643 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1790-4703 |
| authorships[2].author.display_name | Terri Jorgenson |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1322918889, https://openalex.org/I2799886695 |
| authorships[2].affiliations[0].raw_affiliation_string | Clinical Pharmacy Practice Office, Pharmacy Benefits Management, Veterans Health Administration, Department of Veterans Affairs, Washington, DC, USA |
| authorships[2].institutions[0].id | https://openalex.org/I1322918889 |
| authorships[2].institutions[0].ror | https://ror.org/05rsv9s98 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1322918889 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | United States Department of Veterans Affairs |
| authorships[2].institutions[1].id | https://openalex.org/I2799886695 |
| authorships[2].institutions[1].ror | https://ror.org/05eq41471 |
| authorships[2].institutions[1].type | government |
| authorships[2].institutions[1].lineage | https://openalex.org/I1322918889, https://openalex.org/I2799886695 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | Veterans Health Administration |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Terri L. Jorgenson |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Clinical Pharmacy Practice Office, Pharmacy Benefits Management, Veterans Health Administration, Department of Veterans Affairs, Washington, DC, USA |
| authorships[3].author.id | https://openalex.org/A5026680996 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5467-1553 |
| authorships[3].author.display_name | Eric J. Hawkins |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210094549, https://openalex.org/I870398029 |
| authorships[3].affiliations[0].raw_affiliation_string | Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA, USA |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I201448701 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I870398029 |
| authorships[3].institutions[0].ror | https://ror.org/03qhz4n98 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I870398029 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Center for Excellence in Education |
| authorships[3].institutions[1].id | https://openalex.org/I201448701 |
| authorships[3].institutions[1].ror | https://ror.org/00cvxb145 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I201448701 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | University of Washington |
| authorships[3].institutions[2].id | https://openalex.org/I4210094549 |
| authorships[3].institutions[2].ror | https://ror.org/00ky3az31 |
| authorships[3].institutions[2].type | healthcare |
| authorships[3].institutions[2].lineage | https://openalex.org/I1322918889, https://openalex.org/I2799886695, https://openalex.org/I4210094549, https://openalex.org/I4210138024 |
| authorships[3].institutions[2].country_code | US |
| authorships[3].institutions[2].display_name | VA Puget Sound Health Care System |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Eric J. Hawkins |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA, USA, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA |
| authorships[4].author.id | https://openalex.org/A5036614428 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2453-8871 |
| authorships[4].author.display_name | Adam J. Gordon |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210089864 |
| authorships[4].affiliations[0].raw_affiliation_string | Vulnerable Veteran Innovative Patient-Aligned-Care-Team (VIP) Initiative, Veterans Administration Health Systems Research (VA HSR) Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, UT, USA |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I223532165 |
| authorships[4].affiliations[1].raw_affiliation_string | Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA |
| authorships[4].institutions[0].id | https://openalex.org/I223532165 |
| authorships[4].institutions[0].ror | https://ror.org/03r0ha626 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I223532165 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | University of Utah |
| authorships[4].institutions[1].id | https://openalex.org/I4210089864 |
| authorships[4].institutions[1].ror | https://ror.org/007fyq698 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I1322918889, https://openalex.org/I2799886695, https://openalex.org/I4210089864, https://openalex.org/I4210113540 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | VA Salt Lake City Healthcare System |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Adam J. Gordon |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA, Vulnerable Veteran Innovative Patient-Aligned-Care-Team (VIP) Initiative, Veterans Administration Health Systems Research (VA HSR) Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, UT, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1177/29768357251381070 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-17T00:00:00 |
| display_name | The Roles, Activities, and Opportunities of Clinical Pharmacists in a National Initiative to Improve Office-Based Buprenorphine Care |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T09:56:04.775090 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1177/29768357251381070 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4390648488 |
| best_oa_location.source.issn | 2976-8357 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2976-8357 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Substance Use Research and Treatment |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Substance Use: Research and Treatment |
| best_oa_location.landing_page_url | https://doi.org/10.1177/29768357251381070 |
| primary_location.id | doi:10.1177/29768357251381070 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4390648488 |
| primary_location.source.issn | 2976-8357 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2976-8357 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Substance Use Research and Treatment |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Substance Use: Research and Treatment |
| primary_location.landing_page_url | https://doi.org/10.1177/29768357251381070 |
| publication_date | 2025-06-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2121927413, https://openalex.org/W2116099128, https://openalex.org/W16848807, https://openalex.org/W2085452823, https://openalex.org/W1991283062, https://openalex.org/W4396872282, https://openalex.org/W4387661163, https://openalex.org/W4396803046, https://openalex.org/W4390411303, https://openalex.org/W4388014060, https://openalex.org/W3116478769, https://openalex.org/W2117659079, https://openalex.org/W2093974065, https://openalex.org/W2044910572, https://openalex.org/W3110782069, https://openalex.org/W4386507943, https://openalex.org/W4379740030, https://openalex.org/W4368370347, https://openalex.org/W2432233204, https://openalex.org/W4383065796, https://openalex.org/W4408949116, https://openalex.org/W3044677262, https://openalex.org/W2896249325, https://openalex.org/W2211865707, https://openalex.org/W4200006760, https://openalex.org/W4391642648, https://openalex.org/W4367693677, https://openalex.org/W4416186641, https://openalex.org/W4322757294, https://openalex.org/W3197866312, https://openalex.org/W4409980376, https://openalex.org/W4408844562, https://openalex.org/W4411433435, https://openalex.org/W4281632642, https://openalex.org/W789546000, https://openalex.org/W2030329606, https://openalex.org/W2059796825, https://openalex.org/W2944434778, https://openalex.org/W2093274439, https://openalex.org/W4411329746, https://openalex.org/W4396988657, https://openalex.org/W4400617501, https://openalex.org/W4405847172, https://openalex.org/W4412438491, https://openalex.org/W4390970184 |
| referenced_works_count | 45 |
| abstract_inverted_index.a | 84, 234, 240, 261, 283 |
| abstract_inverted_index.25 | 137 |
| abstract_inverted_index.37 | 53 |
| abstract_inverted_index.In | 93, 254 |
| abstract_inverted_index.We | 68, 82, 111 |
| abstract_inverted_index.an | 108 |
| abstract_inverted_index.as | 239 |
| abstract_inverted_index.be | 282 |
| abstract_inverted_index.by | 59 |
| abstract_inverted_index.do | 250 |
| abstract_inverted_index.in | 10, 44, 98, 107, 136, 169, 191, 224, 233, 264, 287 |
| abstract_inverted_index.is | 16 |
| abstract_inverted_index.of | 87, 297 |
| abstract_inverted_index.on | 131 |
| abstract_inverted_index.or | 153, 218, 247 |
| abstract_inverted_index.so | 251 |
| abstract_inverted_index.to | 70, 78, 105, 117, 121, 165, 249, 274, 285, 291, 294 |
| abstract_inverted_index.CPP | 134, 275 |
| abstract_inverted_index.The | 26, 126, 270 |
| abstract_inverted_index.Use | 35 |
| abstract_inverted_index.VHA | 54 |
| abstract_inverted_index.all | 187 |
| abstract_inverted_index.and | 49, 76, 149, 178, 194, 196, 205, 221, 266, 277, 295 |
| abstract_inverted_index.are | 63 |
| abstract_inverted_index.can | 22 |
| abstract_inverted_index.for | 5, 33, 159 |
| abstract_inverted_index.had | 152 |
| abstract_inverted_index.may | 281 |
| abstract_inverted_index.not | 64, 123 |
| abstract_inverted_index.the | 38, 119, 166, 255 |
| abstract_inverted_index.use | 7 |
| abstract_inverted_index.via | 103 |
| abstract_inverted_index.(eg, | 141 |
| abstract_inverted_index.CPPs | 60, 88, 97, 122, 163, 228, 259 |
| abstract_inverted_index.Care | 32 |
| abstract_inverted_index.Most | 227 |
| abstract_inverted_index.also | 112 |
| abstract_inverted_index.care | 14, 173, 180 |
| abstract_inverted_index.drug | 208 |
| abstract_inverted_index.pain | 50, 170 |
| abstract_inverted_index.play | 260 |
| abstract_inverted_index.risk | 144 |
| abstract_inverted_index.role | 263 |
| abstract_inverted_index.side | 216 |
| abstract_inverted_index.test | 209 |
| abstract_inverted_index.they | 151, 231 |
| abstract_inverted_index.this | 24 |
| abstract_inverted_index.well | 65 |
| abstract_inverted_index.were | 101, 243 |
| abstract_inverted_index.work | 232 |
| abstract_inverted_index.(VHA) | 30 |
| abstract_inverted_index.2023, | 95 |
| abstract_inverted_index.72.7% | 222 |
| abstract_inverted_index.90.9% | 203, 211 |
| abstract_inverted_index.March | 94 |
| abstract_inverted_index.Train | 37 |
| abstract_inverted_index.after | 199 |
| abstract_inverted_index.care, | 46 |
| abstract_inverted_index.care. | 25, 299 |
| abstract_inverted_index.email | 104 |
| abstract_inverted_index.known | 96 |
| abstract_inverted_index.local | 114 |
| abstract_inverted_index.model | 284 |
| abstract_inverted_index.often | 237 |
| abstract_inverted_index.other | 288 |
| abstract_inverted_index.roles | 135 |
| abstract_inverted_index.state | 147 |
| abstract_inverted_index.tasks | 140 |
| abstract_inverted_index.urine | 207 |
| abstract_inverted_index.(CPPs) | 21 |
| abstract_inverted_index.B-MOUD | 43, 56, 138, 200, 213, 225, 245, 278, 298 |
| abstract_inverted_index.Health | 28 |
| abstract_inverted_index.Nearly | 186 |
| abstract_inverted_index.Opioid | 34 |
| abstract_inverted_index.SCOUTT | 62, 90, 99, 115, 257, 272 |
| abstract_inverted_index.access | 293 |
| abstract_inverted_index.across | 52 |
| abstract_inverted_index.acting | 238 |
| abstract_inverted_index.clinic | 132 |
| abstract_inverted_index.health | 176, 182, 289 |
| abstract_inverted_index.known. | 66 |
| abstract_inverted_index.mental | 47, 175, 181 |
| abstract_inverted_index.online | 109 |
| abstract_inverted_index.opioid | 6 |
| abstract_inverted_index.roles, | 73 |
| abstract_inverted_index.sought | 69 |
| abstract_inverted_index.survey | 86, 128, 167 |
| abstract_inverted_index.within | 61, 89 |
| abstract_inverted_index.(22.7%) | 184 |
| abstract_inverted_index.(95.5%) | 188, 229 |
| abstract_inverted_index.B-MOUD. | 80, 160, 269 |
| abstract_inverted_index.CPPs’ | 72 |
| abstract_inverted_index.Design: | 81 |
| abstract_inverted_index.Stepped | 31 |
| abstract_inverted_index.Trainer | 39 |
| abstract_inverted_index.VHA’s | 256, 271 |
| abstract_inverted_index.clinics | 51, 100 |
| abstract_inverted_index.desired | 154, 248 |
| abstract_inverted_index.effects | 217 |
| abstract_inverted_index.efforts | 280 |
| abstract_inverted_index.emailed | 113 |
| abstract_inverted_index.emulate | 286 |
| abstract_inverted_index.examine | 71 |
| abstract_inverted_index.expert, | 242 |
| abstract_inverted_index.forward | 118 |
| abstract_inverted_index.health, | 48 |
| abstract_inverted_index.improve | 292 |
| abstract_inverted_index.intake, | 143 |
| abstract_inverted_index.invited | 102 |
| abstract_inverted_index.leaders | 116 |
| abstract_inverted_index.leading | 265 |
| abstract_inverted_index.patient | 142, 197 |
| abstract_inverted_index.primary | 45, 172, 179 |
| abstract_inverted_index.provide | 79 |
| abstract_inverted_index.related | 139 |
| abstract_inverted_index.survey. | 110 |
| abstract_inverted_index.systems | 290 |
| abstract_inverted_index.typical | 74 |
| abstract_inverted_index.whether | 150 |
| abstract_inverted_index.working | 168 |
| abstract_inverted_index.(22.7%), | 177 |
| abstract_inverted_index.(27.3%), | 174, 246 |
| abstract_inverted_index.(40.9%), | 171 |
| abstract_inverted_index.(86.4%). | 252 |
| abstract_inverted_index.(B-MOUD) | 9 |
| abstract_inverted_index.(SCOUTT) | 41 |
| abstract_inverted_index.Clinical | 18 |
| abstract_inverted_index.Disorder | 36 |
| abstract_inverted_index.Methods: | 92 |
| abstract_inverted_index.Results: | 161 |
| abstract_inverted_index.Veterans | 27 |
| abstract_inverted_index.approach | 273 |
| abstract_inverted_index.assisted | 223 |
| abstract_inverted_index.disorder | 8 |
| abstract_inverted_index.gathered | 129 |
| abstract_inverted_index.invited. | 125 |
| abstract_inverted_index.naloxone | 192 |
| abstract_inverted_index.provided | 58 |
| abstract_inverted_index.reported | 189 |
| abstract_inverted_index.results, | 210 |
| abstract_inverted_index.reviewed | 204 |
| abstract_inverted_index.settings | 15 |
| abstract_inverted_index.anonymous | 127 |
| abstract_inverted_index.authority | 158 |
| abstract_inverted_index.conducted | 212 |
| abstract_inverted_index.education | 193 |
| abstract_inverted_index.follow-up | 214 |
| abstract_inverted_index.indicated | 230 |
| abstract_inverted_index.initially | 124 |
| abstract_inverted_index.outcomes) | 220 |
| abstract_inverted_index.performed | 83 |
| abstract_inverted_index.responded | 164 |
| abstract_inverted_index.settings, | 133 |
| abstract_inverted_index.settings. | 185 |
| abstract_inverted_index.specialty | 13 |
| abstract_inverted_index.substance | 156 |
| abstract_inverted_index.treatment | 4, 219 |
| abstract_inverted_index.(assessing | 215 |
| abstract_inverted_index.Initiative | 40 |
| abstract_inverted_index.Twenty-two | 162 |
| abstract_inverted_index.activities | 57 |
| abstract_inverted_index.controlled | 155 |
| abstract_inverted_index.facilitate | 23 |
| abstract_inverted_index.integrated | 183 |
| abstract_inverted_index.invitation | 120 |
| abstract_inverted_index.licensure, | 148 |
| abstract_inverted_index.management | 198, 276, 296 |
| abstract_inverted_index.medication | 3, 241 |
| abstract_inverted_index.pharmacist | 19 |
| abstract_inverted_index.team-based | 235 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Conclusion: | 253 |
| abstract_inverted_index.Initiative, | 258 |
| abstract_inverted_index.Objectives: | 67 |
| abstract_inverted_index.activities, | 75 |
| abstract_inverted_index.assessment, | 145 |
| abstract_inverted_index.environment | 236 |
| abstract_inverted_index.facilities. | 55, 91 |
| abstract_inverted_index.implemented | 42 |
| abstract_inverted_index.information | 130 |
| abstract_inverted_index.initiation. | 201, 226 |
| abstract_inverted_index.interpreted | 206 |
| abstract_inverted_index.involvement | 190 |
| abstract_inverted_index.participate | 106 |
| abstract_inverted_index.prescribing | 244, 279 |
| abstract_inverted_index.significant | 262 |
| abstract_inverted_index.Implementing | 1 |
| abstract_inverted_index.challenging. | 17 |
| abstract_inverted_index.distribution | 195 |
| abstract_inverted_index.facilitating | 268 |
| abstract_inverted_index.initiation), | 146 |
| abstract_inverted_index.prescriptive | 157 |
| abstract_inverted_index.Additionally, | 202 |
| abstract_inverted_index.buprenorphine | 2 |
| abstract_inverted_index.non-addiction | 12 |
| abstract_inverted_index.office-based, | 11 |
| abstract_inverted_index.opportunities | 77 |
| abstract_inverted_index.practitioners | 20 |
| abstract_inverted_index.collaboratively | 267 |
| abstract_inverted_index.cross-sectional | 85 |
| abstract_inverted_index.Administration’s | 29 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile |